Clinical Trial Biorepository & Archiving Solutions Market (By Service: Biorepository Services, Archiving Solution Services; By Product: Preclinical Products, Clinical Products) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Published Date : Sep 2021 | No. of Pages : 150+ Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Clinical Trial Biorepository & Archiving Solutions Market, By Service

7.1.  Clinical Trial Biorepository & Archiving Solutions Market, by Service, 2021-2030

7.1.1.    Biorepository Services

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Archiving Solution Services

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Clinical Trial Biorepository & Archiving Solutions Market, By Product

8.1.  Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2021-2030

8.1.1.    Preclinical Products

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Clinical Products

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Clinical Trial Biorepository & Archiving Solutions Market, By Phase

9.1.  Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2021-2030

9.1.1.    Phase I

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Phase II

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Phase III

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Phase IV

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Clinical Trial Biorepository & Archiving Solutions Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Service (2017-2030)

10.1.2.  Market Revenue and Forecast, by Product (2017-2030)

10.1.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Service (2017-2030)

10.2.2.  Market Revenue and Forecast, by Product (2017-2030)

10.2.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Service (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Service (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Service (2017-2030)

10.3.2.  Market Revenue and Forecast, by Product (2017-2030)

10.3.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Service (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Service (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Service (2017-2030)

10.4.2.  Market Revenue and Forecast, by Product (2017-2030)

10.4.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Service (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Service (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Service (2017-2030)

10.5.2.  Market Revenue and Forecast, by Product (2017-2030)

10.5.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

Chapter 11.  Company Profiles

11.1.              Brooks Life Science

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Patheon

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Precision for Medicine, Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Medpace

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              LabCorp Drug Development

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              ATCC

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Q2 Solutions

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Labconnect

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Charles River Laboratories

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Cell&Co

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Pupillometer Market (By Mobility: Table-top, Hand-held; By Type: Video, Digital; By End-use: Hospitals, Eye Clinics; By Application: Ophthalmology, Oncology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    North America And Europe Preclinical Medical Device Testing Services Market (By Service: Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Cell Banking Outsourcing Market (By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking; By Cell Type; By Phase) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Biologics Contract Development Market (By Source: Mammalian, Microbial; By Product Service Type; By Indication: Oncology, Immunological Disorders) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Plasmid DNA Contract Manufacturing Market (By Application; By Therapeutic Area; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...